Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.48 - $0.74 $49,836 - $76,830
-103,825 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.7 - $1.94 $6,510 - $18,042
9,300 Added 9.84%
103,825 $73,000
Q3 2021

Nov 15, 2021

SELL
$1.82 - $5.71 $90,272 - $283,216
-49,600 Reduced 34.41%
94,525 $174,000
Q2 2021

Aug 16, 2021

SELL
$5.22 - $7.33 $570,546 - $801,169
-109,300 Reduced 43.13%
144,125 $836,000
Q1 2021

May 17, 2021

BUY
$4.0 - $10.28 $517,000 - $1.33 Million
129,250 Added 104.09%
253,425 $1.64 Million
Q4 2020

Feb 16, 2021

BUY
$2.43 - $4.68 $301,745 - $581,139
124,175 New
124,175 $457,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.